Halozyme Therapeutics Inc. Common Stock vs MP Materials — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while MP Materials trades at $46.15 (market cap $8.22B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, MP Materials nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and MP Materials for 11 Days on average.
| HALO | MP | |
|---|---|---|
Market Cap | $12.58B | $8.22B |
Volume | 2,179,278 | 5,457,792 |
Sector | Health | Basic Materials |
52-Week High | $115.22 | $98.65 |
52-Week Low | $61.63 | $38.10 |
Typical Hold Time | 1 Days | 11 Days |
Enterprise Value | $14.49B | $7.70B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →MP Materials mines, refines, and manufactures rare earth materials and magnets in the United States. Its products are used in transportation, energy, robotics, defense, and aerospace applications.
Read more on MP →